Starpharma Holdings (SPHRY, $0.56) was a top loser over the last three months, falling -2 to $0.56 per share. A.I.dvisor analyzed 836 stocks in the Biotechnology Industry for the 3-month period ending May 21, 2025, and found that of them (2) exhibited an Uptrend while of them (7) demonstrated a Downtrend.